| Growth Factor Analogs in Neurodegenerative Disorder Assays and Treatments |
| |
|
Institute : National Institute of Neurological Disorders and Stroke (NINDS)
|
| |
| Description of Technology/Invention :
|
|
The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) seeks a Cooperative Research and Development Agreement (CRADA) Collaborator to work with NINDS in the development, manufacture and commercialization of agents than inhibit or induce proliferation and survival of stem cells and precursor cells.
|
|
| |
| Potential Areas of Application : |
● Clinical treatment for Parkinson’s disease and other neurodegenerative disorders by
administration of agents that promote stem cell survival and proliferation
● Increased generation of stem cells in vitro
Market:
● Treatment for neurodegenerative disorders such as Parkinson ’s disease
● Commercial suppliers or large-scale users of stem cells
|
|
| |
| Main Advantages of Technology/Invention
: |
|
| |
| Current State of Development : |
|
| |
| Patent Status : |
| U.S. Provisional Application |
|
| |
| NIH Reference Number: |
|
| |
| Contact Information : |
| Martha T. Lubet Ph.D., NINDS Technology Transfer by TTB/ NCI |
| Phone: 301 435-3120 |
Email: lubetm@mail.nih.gov
|
|
| |
| |
| Last Updated: 1/25/2008 |
